🧬 Coming soon: Rapid Microbial Screen.Sterility screening results in hours, not 14 days.Get notified →
PuriLab Analytical
COA/TZ-2026-068Verified
Save as PDF

Certificate of Analysis

PuriLab Analytical

Tirzepatide 40 mg

TZ-2026-068Lot green capAnalyzed November 14, 2026
Tirzepatide 40 mg vial as received

Timeline

Ordered
November 7, 2026
Received
November 11, 2026
Analyzed
November 14, 2026

Sample

Name
Tirzepatide 40 mg
Expected
Tirzepatide
Amount
1 vial, lyophilized powder

Testing

Client
Cute Chem Labs
Test type
Content & purity
Method
HPLC-UV
Content, how much is in it
33.77mg
Label claim: 40 mg
Purity, how clean it is
>99.9%
Measured, not estimated. Purity is calculated from the full chromatogram shown above, and no impurity peaks were detected above the reporting threshold. Results of 99.95% or higher are reported as >99.9%, as 100% purity cannot be demonstrated analytically.

Chromatogram

HPLC-UV

mAU-10001002003000481216202428Retention time (min)18.96
18.96 min, Tirzepatide, >99.9%

Analyst Comments

Lyophilized powder, green-cap vial, received sealed.

Analyst Signature

Max Barrett
Lab Director, PuriLab Analytical
Analysis date: November 14, 2026

Verification Code

TZ-LNQZ-ATN7
Verify at purilab.org/verify/TZ-LNQZ-ATN7

Scan to Verify

TZ-LNQZ-ATN7

Results apply solely to the sample as received and are not representative of any larger lot, batch, or production run. Findings are limited to the analytes stated above. PuriLab Analytical is an independent testing laboratory, is not CLIA certified or ISO 17025 accredited, does not sell or distribute any substance, and makes no representation as to the safety, legality, or fitness of any material for any use.

PuriLab Analyticaladmin@purilab.org
Page 1 of 1